Sen. Dan Kotowski
Filed: 3/23/2010
 
 

 




 

 		












09600SB2060sam003

LRB096 11300 ASK 39519 a






1

AMENDMENT TO SENATE BILL 2060 




2
    AMENDMENT NO. ______. Amend Senate Bill 2060 by replacing 
3
everything after the enacting clause with the following:

 
4
    "Section 5. The Pharmacy Practice Act is amended  by 
5
changing Section 26 as follows:
 
6
    (225 ILCS 85/26)
7
    (Section scheduled to be repealed on January 1, 2018)
8
    Sec. 26. Anti-epileptic drug product selection prohibited.
9
    (a) The General Assembly finds that this Section is 
10
necessary for the immediate preservation of the public peace, 
11
health, and safety.
12
    (b) In this Section:
13
    "Anti-epileptic drug" means (i) any drug prescribed for the 
14
treatment of epilepsy or (ii) a drug used to treat or prevent 
15
seizures.
16
    "Epilepsy" means a neurological condition characterized by 
 


 






09600SB2060sam003
- 2 -
LRB096 11300 ASK 39519 a




1
recurrent seizures.
2
    "Seizure" means a brief disturbance in the electrical 
3
activity of the brain.
4
    (c) When the prescribing physician has indicated on the 
5
original prescription "may not substitute", a pharmacist may 
6
not interchange an anti-epileptic drug or formulation of an 
7
anti-epileptic drug for the treatment of epilepsy without 
8
notification and the documented consent of the prescribing 
9
physician and the patient or the patient's parent, legal 
10
guardian, or spouse.
This Section does not apply to medication 
11
orders issued for anti-epileptic drugs for any in-patient care 
12
in a licensed hospital.

13
    (d) If a pharmacist substitutes any prescription for an 
14
anti-epileptic drug with a drug other than the specific drug 
15
originally prescribed or dispensed, then the pharmacist shall 
16
provide written notice to the patient. 
17
(Source: P.A. 94-936, eff. 6-26-06; 95-689, eff. 10-29-07.)".